# Acamprosate in the Treatment of Binge-Eating Disorder

> **NCT00511940** · PHASE2,PHASE3 · COMPLETED · sponsor: **Lindner Center of HOPE** · enrollment: 40 (estimated)

## Conditions studied

- Binge Eating Disorder

## Interventions

- **DRUG:** acamprosate
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00511940
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511940, "Acamprosate in the Treatment of Binge-Eating Disorder". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00511940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*